For Patients
Find essential information here about ovarian cancer prevention, risk factors, and steps to take if you’ve been newly diagnosed, in treatment or navigating life beyond.
The Clearity Foundation Has Joined OCRA
Together, we’re expanding support, education, and resources for the gynecologic cancer community.
Strengthening Support Through Partnership
Ovarian Cancer Research Alliance (OCRA), the world’s leading ovarian and gynecologic cancer nonprofit, is proud to announce that The Clearity Foundation has combined with OCRA. This important development brings together two of the most respected organizations in the ovarian cancer field, combining OCRA’s leading research, advocacy, and patient support programs with Clearity’s focus on scientific education and support for women and families facing an ovarian cancer diagnosis.
Please explore the resources below to learn more about the expanded support and tools now available.
Support & Resources
OCRA is here for you and your family to answer questions or connect you with resources to help you and offer support.
Research
OCRA has awarded more than 400 grants and invested $140 million in ovarian cancer and related gynecologic cancer research initiatives, becoming the largest global charity devoted to ovarian and related gynecologic cancer research in the world.
Center for Public Policy
OCRA advocates on Capitol Hill to improve research and education, drug and diagnostic safety, and access to quality care for all members of the ovarian and gynecologic cancer community, having helped secure $3.8 billion in federal research and education funding since inception..
Get Involved
Help us get one step closer to a cure. There are so many ways to lend a hand and improve the lives of patients and families impacted by ovarian and all gynecologic cancers.
About
OCRA is the leading organization in the world fighting ovarian and all gynecologic cancers on all fronts while supporting patients and their families.
Related Topics
The FDA Wants to Hear From You at OCRA’s Online Conference
Submit Your Questions for the FDA Listening Session On September 16–17, Ovarian Cancer Research Alliance (OCRA) will host the International Gynecologic Cancer Conference®, the largest conference dedicated to the gynecologic cancer community. Day 2 features a special opportunity: a Listening Session with leaders from the U.S. Food and Drug Administration (FDA). Ask questions about the FDA’s … Continued
September is Gynecologic and Ovarian Cancer Awareness Month
About Gynecologic and Ovarian Cancer Awareness Month September is recognized nationwide as Gynecologic and Ovarian Cancer Awareness Month, a dedicated time to raise awareness for all gynecologic cancers. Throughout the month, OCRA joins forces with patients, caregivers, and supporters to amplify our voices. We focus on educating the public about risks and symptoms, highlighting the … Continued
The Overview: July 2026
SummeRun Raises $260,000+ for Research, Hope and Progress Nearly one thousand runners, walkers, survivors, families, friends, and supporters showed up at Seattle’s Seward Park on Sunday, July 12th, for the 33rd annual Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, raising more than $260,000 for research and programs that support the gynecologic cancer community. The … Continued